Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Capital Reinvestment Ratio
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥22.41 Million) in capital expenditures (CN¥7.07 Million). See 688193 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Rendu Biotechnology Co. Ltd. A Capital Reinvestment Ratio (2019–2025)
This chart tracks Shanghai Rendu Biotechnology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025. For live market cap and broader valuation context, see market cap of Shanghai Rendu Biotechnology Co. Ltd. A.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CN¥22.41 Million | CN¥7.07 Million | ▼ -26.8% |
| 2024 | 0.43x | CN¥24.39 Million | CN¥10.52 Million | ▼ -63.6% |
| 2023 | 1.19x | CN¥17.19 Million | CN¥20.39 Million | ▲ +143.9% |
| 2021 | 0.49x | CN¥54.44 Million | CN¥26.48 Million | ▲ +189.7% |
| 2020 | 0.17x | CN¥92.61 Million | CN¥15.55 Million | ▼ -95.8% |
| 2019 | 4.01x | CN¥13.67 Million | CN¥54.83 Million | — |